Archives of Physical Medicine and Rehabilitation
Volume 88, Issue 7 , Pages 891-895 , July 2007

Evaluation and Pharmacologic Management of Symptoms in Cancer Patients Undergoing Acute Rehabilitation in a Comprehensive Cancer Center

  • Ying Guo, MD

      Affiliations

    • Corresponding Author InformationReprint requests to Ying Guo, MD, Dept of Palliative Care and Rehabilitation Medicine, Section of Physical Medicine and Rehabilitation, Unit 008, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030
    • ,
  • Beth L. Young, APN
    • ,
  • Susan Hainley, APN
    • ,
  • J. Lynn Palmer, PhD
    • ,
  • Eduardo Bruera, MD

References 

  1. Guo Y, Palmer JL, Kaur G, Hainley S, Young B, Bruera E. Nutritional status of cancer patients and its relationship to function in an inpatient rehabilitation setting. Support Care Cancer. 2005;13:169–175
  2. Cole RP, Scialla SJ, Bednarz L. Functional recovery in cancer rehabilitation. Arch Phys Med Rehabil. 2000;81:623–627
  3. Marciniak CM, Sliwa JA, Spill G, Heinemann AW, Semik PE. Functional outcome following rehabilitation of the cancer patient. Arch Phys Med Rehabil. 1996;77:54–57
  4. Curt GA. Fatigue in cancer. BMJ. 2001;322:1560
  5. Bartsch HH, Weis J, Moser MT. Cancer-related fatigue in patients attending oncological rehabilitation programs: prevalence, patterns and predictors. Onkologie. 2003;26:51–57
  6. Curt GA, Breitbart W, Cella D, Groopman JE, Hroning JS, Itri LM. Impact of cancer-related fatigue on the lives of patients: new findings from the fatigue coalition. Oncologist. 2000;5:353–360
  7. Cleeland CS. Cancer-related symptoms. Semin Radiat Oncol. 2000;10:175–190
  8. Manocchia M, Keller S, Ware JE. Sleep problems, health-related quality of life, work functioning and health care utilization among the chronically ill. Qual Life Res. 2001;10:331–345
  9. Costello P, Wiseman J, Douglas I, Batten B, Bennett M. Assessing hospice inpatients with pain using numerical rating scales. Palliat Med. 2001;15:257–258
  10. Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991;7:6–9
  11. Chang VT, Hwang SS, Feuerman M. Validation of the Edmonton Symptom Assessment Scale. Cancer. 2000;88:2164–2171
  12. Nekolaichuk CL, Bruera E, Spachynski K, MacEachern T, Hanson J, Maguire TO. A comparison of patient and proxy symptom assessments in advanced cancer patients. Palliat Med. 1999;13:311–323
  13. Nekolaichuk CL, Maguire TO, Suarez-Almazor M, Rogers WT, Bruera E. Assessing the reliability of patient, nurse, and family caregiver symptom rating in hospitalized advanced cancer patients. J Clin Oncol. 1999;17:3621–3630
  14. Palmer JL, Fisch MJ. Association between symptom distress and survival in outpatients seen in a palliative care cancer center. J Pain Symptom Manage. 2005;29:565–571
  15. Homsi J, Walsh D, Rivera N, et al. Symptom evaluation in palliative medicine: patient report vs systematic assessment. Support Care Cancer 14:444-53.
  16. Fulton C. Patients with metastatic breast cancer: their physical and psychological rehabilitation needs. Int J Rehabil Res. 1999;22:291–301
  17. Kraus T, Haack M, Schuld A, Hinze-Selch D, Koethe D, Pollmacher T. Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine. Pharmacopsychiatry. 2002;35:220–225
  18. Mattox TW. Treatment of unintentional weight loss in patients with cancer. Nutr Clin Pract. 2005;20:400–410
  19. Morley JE. Orexigenic and anabolic agents. Clin Geriatr Med. 2002;18:853–866
  20. Kayacan O, Karnak D, Beder S, et al. Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients. Am J Clin Oncol. 2006;29:328–335
  21. Lelli G, Montanari M, Gilli G, Scapoli D, Antonietti C, Scapoli D. Treatment of the cancer anorexia-cachexia syndrome: a critical reappraisal. J Chemother. 2003;15:220–225
  22. Bruera E, Belzile M, Neumann C, Harsanyi Z, Babul N, Darke A. A double blind, crossover study of controlled release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. J Pain Symptom Manage. 2000;19:427–435
  23. Bruera E, MacEachern TJ, Spachynski KA, et al. Comparison of the efficacy, safety, and pharmacokinetics of controlled release and immediate release metoclopramide for the management of chronic nausea in patients with advanced cancer. [published erratum in: Cancer 1995;75:1733] Cancer. 1994;74:3204–3211
  24. Collins SL, Moore RA, McQuay HJ. The visual analogue pain intensity scale: what is moderate pain in millimetres. Pain. 1997;72:95–97
  25. Vignaroli E, Pace EA, Willey J, Palmer JL, Zhang T, Bruera E. The Edmonton Symptom Assessment System as a screening tool for depression and anxiety. J Palliat Med. 2006;9:296–303
  26. Koopmans GT, Donker MC, Rutten FH. Length of hospital stay and health services use of medical inpatients with comorbid noncognitive mental disorders: a review of the literature. Gen Hosp Psychiatry. 2005;27:44–56
  27. American Cancer Society. Cancer facts and figures 2006. Atlanta: American Cancer Society; 2006;Available at: http://www.cancer.org/downloads/STT/CAFF2006PWSecured.pdf. Accessed March 9, 2007
  28. Courneya KS, Keats MR, Turner AR. Physical exercise and quality of life in cancer patients following high dose chemotherapy and autologous bone marrow transplantation. Psychooncology. 2000;9:127–136

 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated.

PII: S0003-9993(07)00259-6

doi: 10.1016/j.apmr.2007.03.032

Archives of Physical Medicine and Rehabilitation
Volume 88, Issue 7 , Pages 891-895 , July 2007

Article Tools

* Image Usage & Resolution